• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔白斑非手术治疗综述

A review of the nonsurgical treatment of oral leukoplakia.

作者信息

Ribeiro Adriana Spinola, Salles Patrícia Ribeiro, da Silva Tarcília Aparecida, Mesquita Ricardo Alves

机构信息

Department of Oral Surgery, Medicine and Pathology, Dental School, Federal University of Minas Gerais, CEP 31.270-901, Belo Horizonte, Minas Gerais, Brazil.

出版信息

Int J Dent. 2010;2010:186018. doi: 10.1155/2010/186018. Epub 2010 Feb 23.

DOI:10.1155/2010/186018
PMID:20339486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2836849/
Abstract

The aim of this paper was to assess the nonsurgical treatment of oral leukoplakia (OL). A medline search from 1983 to 2009 was conducted. The topical or systemic nonsurgical treatments or combination of both was reviewed. The primary outcomes of interest were clinical resolution, malignant transformation, follow-up, and recurrence of OL. Studies showed a rate higher than 50% of clinical resolution with photodynamic therapy, beta-carotene, lycopene, or vitamin A. Few studies reported rates of recurrence from 5 to 67% and of malignant transformation from 8 to 23%. There is a lack of randomized clinical trials that assess the effectiveness of nonsurgical treatment of OL. At this time, randomized controlled trials for nonsurgical treatment of OL demonstrate no evidence of effective treatment in preventing malignant transformation and recurrence. It reinforces that even after clinical resolution, OL should be regularly followed.

摘要

本文旨在评估口腔白斑(OL)的非手术治疗。对1983年至2009年的医学文献数据库进行了检索。回顾了局部或全身非手术治疗或两者联合治疗。主要关注的结果是临床缓解、恶变、随访及OL复发。研究表明,光动力疗法、β-胡萝卜素、番茄红素或维生素A的临床缓解率高于50%。少数研究报告复发率为5%至67%,恶变率为8%至23%。缺乏评估OL非手术治疗有效性的随机临床试验。目前,OL非手术治疗的随机对照试验表明,没有证据显示在预防恶变和复发方面有有效治疗方法。这进一步强调,即使临床缓解后,OL也应定期随访。

相似文献

1
A review of the nonsurgical treatment of oral leukoplakia.口腔白斑非手术治疗综述
Int J Dent. 2010;2010:186018. doi: 10.1155/2010/186018. Epub 2010 Feb 23.
2
Interventions for treating oral leukoplakia.治疗口腔白斑的干预措施。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD001829. doi: 10.1002/14651858.CD001829.pub3.
3
Interventions for treating oral leukoplakia.治疗口腔白斑的干预措施。
Cochrane Database Syst Rev. 2004(3):CD001829. doi: 10.1002/14651858.CD001829.pub2.
4
Interventions for treating oral leukoplakia.治疗口腔白斑的干预措施。
Cochrane Database Syst Rev. 2001(4):CD001829. doi: 10.1002/14651858.CD001829.
5
Systematic review of randomized trials for the treatment of oral leukoplakia.口腔白斑病治疗随机试验的系统评价
J Dent Educ. 2002 Aug;66(8):896-902.
6
Chemoprevention in oral leukoplakia: challenges and current landscape.口腔白斑的化学预防:挑战与当前态势
Front Oral Health. 2023 May 24;4:1191347. doi: 10.3389/froh.2023.1191347. eCollection 2023.
7
Although leukoplakia responds to some treatments relapses and adverse effects are common.虽然白斑对某些治疗有反应,但复发和不良反应很常见。
Evid Based Dent. 2005;6(1):15-6. doi: 10.1038/sj.ebd.6400311.
8
Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial.低剂量β-胡萝卜素和维生素C补充剂治疗口腔白斑:一项随机对照试验。
Int J Cancer. 2015 Apr 1;136(7):1708-17. doi: 10.1002/ijc.29156. Epub 2014 Sep 5.
9
Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis.口腔白斑的激光切除术:它会影响复发和恶变吗?一项系统评价与荟萃分析。
Oral Oncol. 2020 Jun 12;109:104850. doi: 10.1016/j.oraloncology.2020.104850.
10
A comparative study to evaluate the therapeutic effects of nutraceuticals in oral leukoplakia:- A randomized clinical trail.一项评估营养保健品治疗口腔白斑疗效的对比研究:一项随机临床试验。
Natl J Maxillofac Surg. 2023 Sep-Dec;14(3):413-419. doi: 10.4103/njms.njms_25_23. Epub 2023 Nov 10.

引用本文的文献

1
Evaluation of Clinical Outcomes and Recurrence After Surgical Excision of Oral Leukoplakia: A Prospective Cohort Study.口腔白斑手术切除后临床结局及复发情况的评估:一项前瞻性队列研究。
Cureus. 2024 Oct 16;16(10):e71593. doi: 10.7759/cureus.71593. eCollection 2024 Oct.
2
Longitudinal Study of Oral Precancerous Lesions: Transformation Rate and Predictive Markers for Malignancy.口腔癌前病变的纵向研究:恶变率及恶性预测标志物
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2555-S2557. doi: 10.4103/jpbs.jpbs_301_24. Epub 2024 Jul 31.
3
Cryotherapy for oral potentially malignant disorders.口腔潜在恶性疾病的冷冻治疗
Bioinformation. 2023 Dec 31;19(13):1377-1382. doi: 10.6026/973206300191377. eCollection 2023.
4
Management of zygomatic fractures using different surgical approaches.采用不同手术入路治疗颧骨骨折
Bioinformation. 2023 Dec 31;19(13):1371-1376. doi: 10.6026/973206300191371. eCollection 2023.
5
Community cancer screening at primary care level in Northern India: determinants and policy implications for cancer prevention.印度北部初级保健层面的社区癌症筛查:癌症预防的决定因素和政策意义。
Fam Med Community Health. 2023 Dec 17;11(Suppl 1):e002397. doi: 10.1136/fmch-2023-002397.
6
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer.一种纳米工程化的局部经黏膜顺铂递药系统在动物模型和口腔癌患者中诱导抗肿瘤反应。
Nat Commun. 2022 Aug 17;13(1):4829. doi: 10.1038/s41467-022-31859-3.
7
Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer.口腔潜在恶性疾病:病因、发病机制及向口腔癌的转变
Front Pharmacol. 2022 Apr 20;13:825266. doi: 10.3389/fphar.2022.825266. eCollection 2022.
8
Dietary Carotenoids in Head and Neck Cancer-Molecular and Clinical Implications.饮食类胡萝卜素对头颈部癌症的影响:分子和临床意义。
Nutrients. 2022 Jan 26;14(3):531. doi: 10.3390/nu14030531.
9
The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence.植物化学物在口腔癌预防和治疗中的潜力:证据回顾。
Biomolecules. 2020 Aug 6;10(8):1150. doi: 10.3390/biom10081150.
10
Prevalence of and related risk factors in oral mucosa diseases among residents in the Baoshan District of Shanghai, China.中国上海宝山区居民口腔黏膜疾病的患病率及相关危险因素
PeerJ. 2020 Feb 24;8:e8644. doi: 10.7717/peerj.8644. eCollection 2020.

本文引用的文献

1
Mass spectrometry approaches for vitamin E research.
Biochem Soc Trans. 2008 Oct;36(Pt 5):1066-70. doi: 10.1042/BST0361066.
2
Protective effect of lycopene in cardiovascular disease.番茄红素在心血管疾病中的保护作用。
Eur Rev Med Pharmacol Sci. 2008 May-Jun;12(3):183-90.
3
Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management.口腔和口咽黏膜的潜在恶性疾病;术语、分类和当前的治疗概念。
Oral Oncol. 2009 Apr-May;45(4-5):317-23. doi: 10.1016/j.oraloncology.2008.05.016. Epub 2008 Jul 31.
4
Management of potentially malignant disorders: evidence and critique.潜在恶性疾病的管理:证据与批判
J Oral Pathol Med. 2008 Feb;37(2):63-9. doi: 10.1111/j.1600-0714.2007.00575.x.
5
Natural history of potentially malignant oral lesions and conditions: an overview of the literature.潜在恶性口腔病变和状况的自然史:文献综述
J Oral Pathol Med. 2008 Jan;37(1):1-10. doi: 10.1111/j.1600-0714.2007.00579.x.
6
Nomenclature and classification of potentially malignant disorders of the oral mucosa.口腔黏膜潜在恶性疾病的命名与分类
J Oral Pathol Med. 2007 Nov;36(10):575-80. doi: 10.1111/j.1600-0714.2007.00582.x.
7
Photodynamic therapy in dentistry.牙科中的光动力疗法。
J Dent Res. 2007 Aug;86(8):694-707. doi: 10.1177/154405910708600803.
8
Fenretinide activity in retinoid-resistant oral leukoplakia.非维生素A酸类视黄醛在抗维甲酸类口腔白斑中的活性
Clin Cancer Res. 2006 May 15;12(10):3109-14. doi: 10.1158/1078-0432.CCR-05-2636.
9
Evaluation of the clinical and histological effectiveness of isotretinoin in the therapy of oral leukoplakia: ten years of experience: is management still up to date and effective?异维A酸治疗口腔白斑的临床及组织学疗效评估:十年经验:当前治疗方法是否仍与时俱进且有效?
Methods Find Exp Clin Pharmacol. 2006 Mar;28(2):115-9. doi: 10.1358/mf.2006.28.2.977843.
10
Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.外用5-氨基酮戊酸介导的光动力疗法成功治疗口腔疣状增生和口腔白斑。
Lasers Surg Med. 2005 Aug;37(2):114-22. doi: 10.1002/lsm.20214.